云南白药(000538) - 2017 Q1 - 季度财报(更新)
YUNNAN BAIYAOYUNNAN BAIYAO(SZ:000538)2017-05-05 16:00

Financial Performance - The company's revenue for Q1 2017 was CNY 5,908,715,879.97, representing a 14.28% increase compared to CNY 5,170,468,851.67 in the same period last year[8]. - Net profit attributable to shareholders was CNY 725,141,944.09, up 16.60% from CNY 621,924,173.77 year-on-year[8]. - The net profit after deducting non-recurring gains and losses was CNY 694,034,309.47, reflecting a 15.24% increase from CNY 602,277,066.43 in the previous year[8]. - The basic earnings per share increased to CNY 0.70, a rise of 16.60% compared to CNY 0.60 in the same quarter last year[8]. - The total assets at the end of the reporting period were CNY 25,265,687,462.02, which is a 2.76% increase from CNY 24,586,646,034.03 at the end of the previous year[8]. - The net assets attributable to shareholders increased to CNY 16,450,809,981.60, marking a 4.61% rise from CNY 15,725,668,037.51 at the end of the last year[8]. - The weighted average return on equity was 4.47%, slightly down from 4.49% in the previous year[8]. Cash Flow - The net cash flow from operating activities was negative at CNY -861,869,790.21, a significant decrease of 193.33% compared to CNY 923,462,534.98 in the same period last year[8]. - Net cash flow from operating activities decreased by 193.33% to -¥861,869,790.21, with cash paid for goods and services increasing by ¥1.193 billion, a rise of 28.16% compared to the previous period[18]. - Investment activities generated a net cash flow of ¥919,915,730.54, a significant increase of 4490.33% compared to the previous year[18]. - Financial expenses turned positive with a decrease of 112.35%, resulting in income of -¥2,528,577.59 due to increased interest income[18]. Expenses and Liabilities - The company reported a 41.88% increase in selling expenses to ¥869,938,773.08, driven by higher revenue[18]. - The company recognized an asset impairment loss of ¥7,545,707.48, a dramatic increase of 742912.03% compared to the previous year, due to inventory write-downs[18]. - Tax and surcharges increased by 52.64% to ¥38,773,760.92, reflecting higher income levels[18]. - Long-term borrowings decreased by 59.02% to ¥2,500,000.00, as the company repaid loans from both the parent company and its subsidiary[18]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 38,788[12]. - No overdue commitments from actual controllers, shareholders, related parties, acquirers, or other related parties during the reporting period[26]. - No significant changes in expected cumulative net profit from the beginning of the year to the next reporting period[27]. - No non-operating fund occupation by controlling shareholders or related parties during the reporting period[32]. Regulatory and Corporate Actions - The company received a notification from the Ministry of Commerce regarding the approval of the acquisition by Xinhua Group, allowing the transaction to proceed without further review[19]. - No violations regarding external guarantees during the reporting period[31]. - No securities investments during the reporting period[28]. Investigations and Discussions - Multiple on-site investigations conducted with various institutions to understand the company's mixed reform and business development[29]. - On-site investigations included discussions on new product launches and business development with institutions like Zhongtai Securities and Credit Suisse[30].